Travel pass: Pros may outweigh cons
IATA’s mobile application will allow travellers to store and manage certifications for Covid-19 tests or ...
Natco Pharma's corporate office in Hyderabad
Natco Pharma Ltd is in the process of steadily expanding its crop health sciences and agriculture business vertical, leveraging its strengths in synthetic chemistry and research & development (R&D) capabilities across sectors.
The Hyderabad-based company is “targeting a unique set of molecules which have a business potential in domestic and export markets”, it said in a recent investor presentation.
Natco expects agri business to be a growth lever for the coming years, backed by its recent investments in the segment.
Also read: Natco Pharma Q2 net profit up 73 per cent to Rs 204 cr
It initiated greenfield manufacturing facilities for producing niche agrichemical products in the Nellore District of Andhra Pradesh last year with a total capital investment of ₹100 crore.
The product portfolio consists of crop protection chemicals (insecticides, fungicides and herbicides), organic products (pollination enhancers, plant growth regulators) and Integrated Pest Management (IPM) solutions.
With an in-house R&D Centre for crop protection, Natco is focussing on-field farmer activities, demand generation, farmer demonstrations and awareness and handling statutory needs and requirements.
Its current product pipeline includes chlorantraniliprole (CTPR) and other niche molecules.
In the core business of pharma, Natco has 20 Para IV products in the pipeline for the complex generics market in the US. In the domestic market, the company plans to launch six to eight products a year.
In the second quarter ended September 2020, Natco posted a 73 per cent increase in consolidated net profit at ₹204 crore driven by robust sales, compared to ₹118 crore in the corresponding period of the previous fiscal.
By noon Wednesday, the stock of Natco Pharma was trading at ₹900.35, down 1.39 per cent over its previous close on the BSE.
IATA’s mobile application will allow travellers to store and manage certifications for Covid-19 tests or ...
A 2010 Act to regulate the medical sector flounders in implementation, even as healthcare remains ...
The scheme to boost local medtech manufacturing is timely, especially given the raging pandemic. But ...
Do pilots sleep on their job?
Fiscal stimulus, friendly monetary policy and firm commodity prices point towards normalcy, says the MD and ...
Price correction is a good opportunity for long-term investors to take the plunge
Q4 earnings, along with progress in controlling Covid-19 spread, will be in focus
Do keep in mind that premium may go up in case one of the members has a pre-existing condition
In an age of falling female workforce participation, worsened by the Covid-19 pandemic, policy makers and ...
A 25-member team is on a mission to revive Urdu calligraphy
Of an injured baby goat, young men on motorcycles and political tensions
It’s the birthday of Muttiah Muralitharan — the man who took a staggering 800 test wickets. What better way to ...
Monotype’s 2021 type trends report points to a return to hand and the familiar
As ‘ear-points’ between a company and a customer grow, we are witnessing a rise in audio assets
‘Desi Twitter challenger’ Koo on connecting like-minded folks
Coca-Cola has just introduced an oat milk line in the US under its Simply brand. Smart move, say industry ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor